(Q46756254)

24 December 2017

title

The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL. (English)

1 reference

24 December 2017

author

Ioannis S. Vlachos

8

1 reference

24 December 2017

author name string

Konstantinos K Doumouchtsis

1

1 reference

24 December 2017

Alkis I Kostakis

2

1 reference

24 December 2017

Stergios K Doumouchtsis

3

1 reference

24 December 2017

Eirini I Grapsa

4

1 reference

24 December 2017

Ioanna A Passalidou

5

1 reference

24 December 2017

Marios P Tziamalis

6

1 reference

24 December 2017

Maria V Poulakou

7

1 reference

24 December 2017

Despoina N Perrea

9

1 reference

24 December 2017

publication date

1 January 2008

1 reference

24 December 2017

Hemodialysis International

published in

1 reference

24 December 2017

volume

12

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

100-107

1 reference

24 December 2017

Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Androgens regulate bone resorption activity of isolated osteoclasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Hormonal and biochemical parameters in the determination of osteoporosis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

The actions and interactions of sex steroids and growth factors/cytokines on the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Comparison of the effects of 17beta-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Correlates of osteoprotegerin levels in women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

The effect of a single dose of osteoprotegerin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

Association of Hypogonadism and Estradiol Levels with Bone Mineral Density in Elderly Men from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2008.00249.X

10.1111/J.1542-4758.2008.00249.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017